Genetic risk factors often localize in non-coding regions of the genome with unknown effects on disease etiology. Expression quantitative trait loci (eQTLs) help to explain the regulatory mechanisms underlying the association of genetic risk factors with disease. More mechanistic insights can be derived from knowledge of the context, such as cell type or the activity of signaling pathways, influencing the nature and strength of eQTLs. Here, we generated peripheral blood RNA-seq data from 2,116 unrelated Dutch individuals and systematically identified these context-dependent eQTLs using a hypothesis-free strategy that does not require prior knowledge on the identity of the modifiers. Out of the 23,060 significant cis-regulated genes (false discovery rate ≤ 0.05), 2,743 genes (12%) show context-dependent eQTL effects.
Introduction
The molecular mechanisms underlying the association of genetic risk factors with disease and complex traits are still largely elusive. Many disease-associated genetic variants are found in non-coding parts of the genome 1,2 and thus must have a regulatory effect on expression.
Mapping single nucleotide polymorphisms (SNPs) with an effect on the regulation of gene expression (expression quantitative trait loci, eQTLs) helps to unravel the regulatory networks that underlie physiological traits and diseases [3] [4] [5] [6] [7] [8] . Given differences between the regulatory networks of different cell types, it is not surprising that a substantial fraction of eQTLs are only apparent in specific cell types or tissues [9] [10] [11] [12] [13] [14] . The presence of external stimuli and the activity of internal signaling pathways may also determine the presence and strength of the regulatory effects of eQTLs. For example, a subset of eQTLs in immune cells may only be observed after activation of these cells by immunological triggers [15] [16] [17] [18] [19] [20] . Knowledge of the cellular context in which disease-associated eQTLs are active can help to identify the cell types that are relevant in the pathophysiology; identification of the cell type in which a risk locus shows the most profound effects allows prioritization of variants for functional experiments. Additionally, insights into the activity of signaling pathways modifying eQTL effects help to unravel the regulatory networks underlying disease. Here, we developed and applied a strategy to identify the most important intrinsic and extrinsic factors that modify eQTL effects in blood cells, without making any prior assumptions on the identity of these modifiers. We demonstrate how the eQTLs and their modifiers contribute to better understand the molecular basis of disease.
Results

Main-effect cis-eQTLs
We generated a comprehensive set of cis-eQTLs by sequencing whole peripheral blood mRNA of 2,176 healthy adults from four Dutch cohorts [21] [22] [23] [24] (2, 116 individuals remaining after stringent quality control (Table S1 , Supplementary material)). We quantified gene and exon expression, as well as exon ratios (the proportion of expression of an exon relative to the total expression of all exons of a gene) and polyA ratios (the ratio of the expression in upstream and downstream parts of the 3'-UTRs separated by annotated polyadenylation (polyA) sites) and performed ciseQTL mapping for all of these. We detected cis-eQTL effects for 66% of the protein coding genes tested and 19% of the non-coding genes tested. In total, we found eQTL effects for 23 ,060 different genes (false discovery rate (FDR) ≤ 0.05). We replicated 84% of 6,418 previously reported cis-eQTL genes that we had previously detected in a meta-analysis of 5, 311 array-based blood samples 4 (90% with the same allelic direction) (Table S2 ). This demonstrates the superior statistical power to detect eQTLs when using RNA-seq data (Tables   S2 and S3) . We also observed strong overlap with RNA-seq based cis-eQTLs from EBVtransformed lymphoblastoid cell lines (LCL) 5 (78% of the LCL cis-eQTLs could be replicated, 88% with the same allelic direction), but substantially extended the list of genes that are known to be under genetic regulation (replication results in Supplementary material online, Table S2 ).
In addition to detected gene-level eQTLs, we identified for 21,888 different genes with one or more exon-level QTL effects and 9,777 and 2,322 genes where SNPs affected the inclusion rate of exons and the usage of polyA sites, respectively (Table S3) . A complete catalogue of all our eQTLs can be downloaded and explored via a dedicated browser at http://genenetwork.nl/biosqtlbrowser.
Multiple unlinked SNPs in the same locus may independently influence expression or mRNA processing of the same gene 25 . We analyzed this using stepwise regression of the effects of the top eQTL SNPs. More than half of the cis-regulated genes showed evidence for multiple independent eQTL effects ( Figure 1a , Figure S1 ).
The gene cis-eQTL SNPs are strongly enriched for DNase I footprints, various histone marks and binding sites of multiple transcription factors 26 (Table S4) suggesting that our substantial sample-size enabled us to pinpoint likely causal regulatory variants. Moreover, top eQTL SNPs were significantly enriched for general and blood-cell-type-specific enhancers (as taken from Andersson et al., 2014 27 ), but not for non-blood tissue-specific enhancers (Table S5) . Evidence for the functionality of exon ratio and polyA ratio QTLs in mRNA splicing and polyadenylation is presented in the supplementary material.
One third (2,064 / 32.7%) of previously established genetic risk factors for disease or complex traits (derived from the NHGRI GWAS catalog and a set of reported ImmunoChip associations, P ≤ 5 x 10 -8 ) were in strong linkage disequilibrium (LD r 2 ≥ 0.8) with a top eQTL SNP (Table S6, Figure 1b ). As expected, eQTL effects were predominantly found for SNPs associated with hematological, lipid or immune-related traits. We observed a highly significant enrichment of colocalization of eQTL and GWAS SNPs (LD r 2 ≥ 0.8) for many immune disorders, as compared to height (see supplementary material for details), indicating that our blood cis-eQTLs are highly informative for diseases such as inflammatory bowel disease, multiple sclerosis and rheumatoid arthritis ( Figure 1c ).
Context-dependent eQTLs
The effects of SNPs on gene expression often depend on the cell type or tissue under investigation [9] [10] [11] [12] , and may be modified by external and environmental factors [15] [16] [17] [18] [19] . To identify these context-dependent eQTLs, we developed a hypothesis-free strategy that does not assume any prior knowledge about the factors that may modify the eQTL effects (Figure 2a) .
Instead of using known factors, such as the percentage of neutrophils in blood 28 , in a gene by environment interaction model, we used the expression levels of other genes as interaction factors. Here, we expect that the genes whose expression levels modify eQTLs are proxies of cell types or other intrinsic or extrinsic factors, and we call these genes 'proxy genes'.
To do this in a systematic manner, we ran interaction analyses for all the eQTLs identified for each gene, evaluating each gene for its potential to influence eQTLs and quantifying per gene the extent to which it influenced the complete set of cis-eQTLs. We first identified the proxy gene acting on the highest number of eQTLs. We subsequently corrected the expression data for interaction effects with the top proxy gene and repeated this process in an iterative fashion to find additional independent proxy genes ( Figure 2a ). We first concentrated on the top 10 proxy genes that independently affected, in total, 1,842 unique cis-eQTL genes (Figure 2c ).
An example is shown in Figure 2b . We found a significant eQTL effect of SNP rs1981760 (a SNP associated with leprosy susceptibility) on NOD2 expression. The first top proxy gene, STX3, had a significant interaction effect on this eQTL. Samples with very low expression of STX3 showed only a very weak eQTL on NOD2, whereas samples with very high STX3 expression showed a stronger eQTL effect size. When visualizing this using an interaction plot, a clear divergence in NOD2 expression between samples with different genotypes can be observed (Figure 2b ). Further analysis demonstrated that STX3 expression was strongly correlated (Pearson r = 0.74) with the percentage of neutrophils in the blood, suggesting that STX3 is a proxy for neutrophils. In this example, the eQTL effect is found to be more prominent in neutrophils than in other blood cell types, and the expression of NOD2 found to be lower in carriers of the risk allele compared to carriers of the protective allele. It also confirms a role for neutrophils in the disease for which a genetic association with the locus is found, i.e. leprosy.
To investigate the biological context reflected by the 10 independent proxy genes, we selected, for each of these genes, the top 100 genes showing a nearly identical interaction effect with eQTLs (see Methods and Table S7 for full details). As expected, these genes are highly coexpressed (Figure 2c ), and we refer to such a set of genes as an 'interaction module'.
We first assessed whether these interaction modules might represent markers for specific cell types, and correlated the top 100 genes per module with the blood cell counts measured in our samples (neutrophils, lymphocytes, eosinophils, basophils and monocytes) and assessed their baseline gene expression levels in purified blood cells from the BLUEPRINT consortium 29 .
Based on higher correlation with counts of the corresponding cell type and the higher expression in BLUEPRINT data, we concluded that eight out of the ten modules were strongly associated with specific blood cell types ( Figure 2c and Figure S2 ), namely neutrophils, CD4+
T-cells, NK cells, CD8+ T-cells, monocytes, erythroblasts, macrophages and eosinophils.
The eQTLs modified by cell type proxies were enriched in cell-type-specific signaling pathways ( Figure 2c , Table S8 ). For example, genes for which the cis-eQTL effects were particularly strong in erythroblasts (module 4) had erythrocyte-specific functions. They were also enriched in binding sites for transcription factors involved in erythrocyte development based on ENCODE ChIP-seq data (GATA1, TAL1, GATA2 and MafK, each with enrichment p-values ≤ 10 -5 ) [30] [31] [32] .
For the other modules, we also identified specific transcription factors having established functions in the corresponding cell types (Table S9) . Analysis of eQTL interactions with the blood cell counts measured confirmed the cell-type-dependent effects on neutrophils, lymphocytes, eosinophils and monocytes (Table S10) . However, the comparison with BLUEPRINT expression data showed that our unbiased analysis also identified effects for cell types for which actual cell counts were not available (erythroblasts, CD4+ T-cells and NK cells/CD8+ T-cells), showing the usefulness of such an approach in datasets without comprehensive cell count measurements.
eQTLs that are lymphocyte-dependent and that show a stronger signal in B-, T-or NK cells are expected to replicate better within the in B-cell-derived LCL eQTL data generated by the Geuvadis consortium 5 . We indeed found that replication of the lymphocyte-dependent eQTL effects is higher than our overall replication rate in Geuvadis (Table S11 ) (46% vs 38%, Fisher exact p-value = 0.005). In contrast, for our neutrophil-dependent eQTLs, the replication rate was similar to the overall replication rate (39% vs 38%, Fisher exact p-value = 0.58). Here, however, we observed that these neutrophil-dependent eQTLs are enriched for opposite allelic effects between our data and the Geuvadis results (27% opposite effects, compared to 14% for all overlapping eQTLs, Fisher exact p-value = 8.08 x 10 -5 ). While the Geuvadis LCLs are not a perfect model for any of our lymphoid modules, our replication results do provide further evidence of the cell-type dependent nature of the identified context-dependent eQTLs.
The 10 proxy genes identified using the gene-level eQTLs also affected 4,216 exon-level eQTLs and 572 exon ratio QTLs. Gene function enrichment analysis on the exon-level and exon ratio QTLs showed results similar to that of eQTL genes (Table S8 ), indicating that the proxy genes do not solely represent the factors modulating gene-level eQTLs but also those that affect alternative splicing eQTLs.
Risk factors for immune disorders show context-dependent effects
To demonstrate how eQTLs and their context-specific effects can help to better understand disease, we highlight cis-eQTLs for inflammatory bowel disease (IBD) and rheumatoid arthritis (RA). We performed clustering of the eQTL genes based on co-expression in our dataset. Clustering of these 233 genes revealed a set of 123 genes mainly related to T-cell biology and a set of 110 genes specific to neutrophils and toll-like receptor signaling (Figure 3b and 3c, see Table S13 for full enrichment analysis results), confirming existing knowledge of the cell types relevant in IBD 20, 21 . There was a significant imbalance in the direction of regulation within the Tcell cluster: 54 genes were up-regulated by the IBD risk allele whereas only 29 were downregulated (binominal test p-value: 0.003), suggesting increased T-cell activity in IBD.
Incorporation of exon level eQTLs can be used to better understand gene level eQTLs. For instance, rs727088 lowered CD226 expression. Zooming into the exon QTL effects of this gene, we found two exons that were strongly up-regulated, both of them unique to a non-sense mediate decay (NMD) transcript (as annotated by Ensembl). The other exons showed downregulation by the risk allele, suggesting that a shift to the NMD isoform is lowering overall gene expression levels ( Figure S4 ).
Twelve IBD-linked genes demonstrated context-dependent eQTL effects (Table S12) . Five of these eQTLs were strongest in neutrophils (positive interaction score for module 1) and the genes containing these eQTLs were present in the neutrophil cluster (Figure 3d ). We also observed negative interactions, where the effect becomes smaller in a specific module, e.g. the eQTL effect of rs1728801 regulating ZPF90 (Figure 3f ), a gene that is known to be important in T-helper cells 36 . We found that carriers of the protective allele show increased expression of ZPF90 in CD4+ T-cells, while the risk allele carriers show consistently high expression levels independent of CD4+ T-cells. This indicates that while ZFP90 expression normally is restricted to T-cells this does not apply to carriers of the risk allele which have high expression levels in multiple cell-types, potentially activating T-cell specific pathways in other cells. 
Modules not associated with cell types
We found that most modules represented different cell types, except module 6 and 7. Although (Table S14) . Likewise, the affected eQTL genes can be divided into two groups: those that were positively correlated with SP140 expression and those with negative correlations to SP140. Similarly to the proxy genes, the most significantly enriched pathway for the positively correlated eQTL genes was 'response to type I interferon' (Figure 5b ).
Gene annotations from the interferome database 39 confirmed that the up-regulated eQTL genes are indicative of a type I, but not of a type II interferon response (Figure 5c ). Type I interferon signaling is activated in a viral response and type II interferon signaling is activated upon bacterial response 40 . Both type I and type II interferon signaling result in binding of heterodimers of the STAT1 transcription factor. Unique to type I interferon is that STAT1 forms a complex with STAT2 and IRF9, resulting in the activation of viral response genes. STAT3 activation is also unique to the type I response, resulting in the down-regulation of inflammatory pathways 41 . The eQTLs were enriched for STAT1 (p-value = 4.82 x 10 -04 ), STAT2 (3.12 x 10 -04 ) and STAT3 (4.72 x 10 -05 ) binding sites (based on ENCODE ChIP-seq experiments) (Table S9) .
Motif enrichment analysis 42 on the 25 bp flanking regions of the eQTL SNPs confirmed the enrichment of STAT-binding motifs (Wilcoxon rank-sum test, p-value = 9.61 x 10 -05 ). In support of the modifying effects of viral cues on this set of eQTLs, eQTL genes that have recently been reported as rhinovirus-response QTLs 16 typically have higher interaction z-scores for module 7 than other eQTL genes (Wilcoxon p-value = 0.02). We therefore conclude that the effect of these 145 eQTL genes is dependent on stimulation with type I interferon.
Regulatory network discovery
Each of the aforementioned ten modules demonstrated effects on many (>120) eQTLs.
However, some other factors may also exist that affect more limited numbers of eQTLs. To identify these, we first corrected the expression data for the 10 module interaction effects and then ascertained for each gene-level eQTL whether the eQTL effect size was significantly dependent on the expression of any other gene. This resulted in the identification of an additional set of 901 context-dependent eQTL genes (FDR ≤ 0.05). Of these eQTL interactions,113 could be replicated in Geuvadis LCLs (FDR ≤ 0.05, 94% with the same interaction direction) (Table S15 ). These LCLs are derived from a single cell type so any interaction effect that replicates is unlikely due to cell type specific eQTL effects, but likely reflect an external stimulation or activation of core biological processes. A few of these contextdependent eQTLs enable inference of regulatory networks:
An example is a cis-eQTL effect on the lipid biosynthesis gene FADS2 that is modified by the expression of the sterol regulatory element binding transcription factor SREBF2 (p-value = 4.1 x 10 -14 , p-value in Geuvadis = 0.002) (Figure 6a and 6b) . The eQTL SNP was in close proximity to an SREBF2 binding site (ENCODE ChIP-seq data, Figure 6c ) and it is therefore likely that the SNP modifies the affinity of the FADS2 promoter for SREBPF2. SREBF2 showed a significant We found 109 genes that alter the rs285205 cis-eQTL effect on MYBL2, which encodes a known transcription factor that controls cell division and has a known tumor suppressing function 43 . Co-expression clustering based on these 109 proxy genes revealed six clusters (Figure 6d ). Gene function enrichment analyses on the genes in these clusters revealed that all were related to proliferation or cell cycle checkpoints. Interestingly, only one cluster increased the magnitude of the MYBL2 eQTL effect in contrast to the other clusters, which all repressed this eQTL. This eQTL activating cluster was strongly enriched for "positive regulation of B cell proliferation" (p-value = 1 x 10 -7 ), and the strongest proxy gene in this cluster was FCRLA, which is known to be highly expressed in proliferating B-cells residing in the germinal center of the lymph nodes (centroblasts) 44 . FCRLA is also reported to be highly expressed in lymphoblastoid cell lines, which are in a highly proliferative state 45 . However, in our analysis we had initially only considered genes that where expressed in each of our individuals (see methods), and therefore had not studied low-abundant transcription factor genes. When also including these genes, we observed this cluster of genes is strongly co-expressed with EBF1, a transcription factor that drives B-cell differentiation and proliferation, suggesting that EBF1 might drive the eQTL interaction effect for MYBL2. This was indeed confirmed using ENCODE ChIPseq data in LCLs: we observed strong binding of EBF1 at rs285205 (Figure 6g ). EBF1 is a known player in B-cell differentiation and proliferation and positively correlated to both MYBL2 (r = 0.11, p-value = 6.99 x 10 -7 ) and FCRLA (r = 0.8, p-value ≤ 2.2 x 10 -16 ). Finally, testing EBF1 as a proxy gene directly also revealed a significant interaction (p-value = 1.8 x 10 -14 ) effect (Figure 6f ). As such EBF1 influences MYBL2 gene expression, but because of its binding at SNP rs285205, this SNP likely affects the binding affinity of EBF1. In the Geuvadis dataset these MYBL2 interactions are not significant, however 74% were in the same direction (binominal p-value = 2.2 x 10 -5 ).
Discussion
Using whole blood RNA-seq data we greatly expanded the catalog of SNPs that have a known regulatory function. Our study on 2,116 individuals allowed identification of many independent genetic effects influencing expression levels. We observe co-localization of one third of the disease-and trait-associated variants with eQTL signals, and we observed significantly more overlap for traits related to blood (immunological disorders/metabolic levels) as compared to other traits such as height and BMI, and thus arrive at different conclusions as compared to a recent paper that observed that blood eQTL and IBD variants do not significantly more often colocalize as compared to chance 46 . However, since that analysis used earlier array-based blood eQTL results that had not been imputed to recent reference panels, this suggests that earlier eQTL studies either have lacked sufficient statistical power to identify eQTLs (i.e. limited sample size and/or the use of microarrays instead of RNA-seq) or were unable to fine-map these associations (i.e. imputation to older reference panels). Additionally, the presence of multiple independent regulatory variants might have been missed; while the regulatory effects of nearly 500 GWAS hits were not in strong LD with our top eQTL SNPs, they were in strong LD with our secondary, tertiary or even higher order eQTLs (Figure 1a, Figure S1 ). Moreover, approximately 10% of the GWAS hits did not affect the regulation of overall gene expression levels, but had an impact on mRNA processing because they were found only in the exon, exon ratio or polyAratio QTL analyses (Figure 1b , Table S6 , examples in Supplementary Material online).
To gain a better understanding of the biology behind these regulatory variants, we identified 2,743 context-dependent eQTLs (1,842 in the first 10 modules and 901 in the remainder) and identified many of the determinants that modify these eQTLs. These provide further insight into the cell types in which the genetic risk factors are regulating gene expression and the regulatory networks in which they participate, further refining our findings on GWAS risk loci. Unlike other approaches ( 15, 16, 20 ) , our method does not rely on any prior knowledge or assumptions on differences in cell type composition or naturally occurring stimulations acting on our whole tissue data.
We also observed various examples where eQTLs are influenced by transcription factors that bind to the eQTL SNP. This includes rs968567 that strongly influences FADS2 gene expression and depends on SREBF2 activity, but which also increases risk for rheumatoid arthritis, blood metabolite levels and lipid levels. With future increases in sample-size we expect it might also become possible to observe gene x environment interaction effects for this SNP on these (disease) phenotypes as well.
Our method can easily be applied to other tissues and we expect that many more cell-typedependent eQTLs will become detectable in such datasets once sample-sizes become sufficiently large. This will likely lead to the identification of even more unanticipated intrinsic factors and external stimuli that modify the downstream effects of genetic risk factors. As such our approach complements perturbation experiments to gain better insight in regulatory networks and their stimuli. show that these top 100 genes are strongly correlating per module. This top 100 was used for gene function enrichments (for full results see Table S9 ) and was correlated to known cell proportions. We used BLUEPRINT expression data for sorted populations of blood cells to validate cell-type-specific expression in each module. 
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